Rubivirus rubellae
| Nitazoxanide | RuV | Pyruvate inhibitor | Phase 3 | — | Human pyruvate synthase | |
| Aprotinin | RuV | Serine protease inhibitor | Preclinical | — | Human (multiple) | |
| Brequinar | RuV | DHODH (DHODH) inhibitor | Preclinical | — | Human DHODH | |
| Glycyrrhizin | RuV | — | Preclinical | — | Human TNF | |
| Leflunomide | RuV | Pyrimidine synthesis inhibitor | Preclinical | — | Human DHODH | |
| Mycophenolic acid | RuV | Inosine monophosphate dehydrogenase inhibitor | Preclinical | — | Human IMPDH | |
| Ribavirin | RuV | Nucleoside inhibitor; Guanosine (ribonucleic) analog | Approved (other) | JapanChinaRussia | Viral RNA pol | |
| Sirolimus | RuV | IL-2-dependent T-cell proliferation inhibitor | Preclinical | — | Human PTK |